Phaeton Research Appoints New Operations Director
10/19/2005 5:10:39 PM
Drug delivery problem-solver Phaeton Research (www.phaetonresearch.com), based in Nottingham, UK, has announced the appointment of Dr Shohré Nabahi as its new Operations Director.
The company, re-launched during the Summer of 2003, is part of Prophilian Group, which also includes niche Phase I/IIa CRO Pharmaceutical Profiles (www.pharmprofiles.com), specialises in developing innovative solutions for difficult molecules via customised advanced drug delivery technologies.
Shohré will be responsible for providing direction to Phaeton’s Pharmaceutical R&D group which is involved in developing products from concept to utilisation in Phase I clinical studies. She will also be promoting the involvement of Phaeton Research in developing future drug delivery technologies which will be appropriate for a range of global pharmaceutical and biotechnology companies with 'problem' molecules and would secure the company valuable Intellectual Property.
comments powered by